SQUARE

e-

SQUARE

 
Healthcare online Keeping you up-to-date
VOL.  7     ISSUE:  10  2009 Medical Services Department

SQUARE Pharmaceuticals Ltd.

Features

EDITORIAL TEAM

OMAR AKRAMUR RAB

MBBS, FCGP, FIAGP,

P G Dip. Business Management

MAHFUZUR RAHMAN, MBBS

 

EDITORIAL

Dear Doctor,

 Hope you are enjoying 'e-SQUARE' online healthcare bulletin.

Our current issue focused on some interesting features like -

"Scarless Surgery !", "Soy Fight Cancer !", "Traffic, Dust Alert !", "Higher Dose Better !",  "Depression After Surgery !", "Optical Technology !".

In our regular feature, we have some products information of SQUARE Pharmaceuticals Ltd. as well.

We will appreciate your feedback !

Click on to reply mode.

Yours sincerely,

 

Editorial Team

Reply Mode      : e-square@squaregroup.com

The views expressed in this publication do not necessarily reflect those of its editor or SQUARE Pharmaceuticals Ltd.

 Scarless Surgery !

Scarless Thyroid Surgery

A doctor at Tulane University School of Medicine is the first in the U.S. to remove bad thyroid glands without leaving a scar behind.  The new endoscopic surgery uses the latest Da Vinci three-dimensional, high-definition robotic equipment to make a two-inch incision below the armpit that allows doctors to maneuver a small camera and other instruments between muscles to access the thyroid. The surgeon then controls the robot to pull out the bad tissue back through the armpit incision without any scars. "This is an exciting new treatment option for certain patients who need thyroid surgery but are concerned about having a visible and permanent neck scar," according to the chief of the Endocrine Surgery Section, assistant professor of surgery and adjunct assistant professor of otolaryngology at Tulane. “This technique safely removes the thyroid without leaving so much as a scratch on the neck," the scientist concludes. Only a few surgeons in the United States are trained to perform the "scarless" thyroidectomy surgery, which originated in South Korea by an associate professor of surgery at Yonsei University College of Medicine in Seoul.

SOURCE: Ivanhoe Newswire, November 2009

Return to top

 Soy fight Cancer !

Soy Helps Fight Colon Cancer

It is heard that soy is good for health, but now researchers say it could also help in the fight against colon cancer, the third most deadly type of cancer. The new study, conducted by Children's Hospital and Research Center Oakland, suggests that a component found naturally in soy could be used to help prevent colon cancer. Sphingadienes (SDs), natural lipid molecules found in soy, may be the root of soy's known benefits. "This information is important because we can build on our understanding of the structure and metabolism of SDs in terms of developing new drugs to treat people who already have colon cancer," according to the senior scientist and director of the Cancer Center at Children's Hospital Oakland Research Institute. The scientist first recognized SDs in a study of fruit flies, which are often used during research to study the genetics of human diseases. She found that SDs toxicity to cells may prevent colon cancer just like traditional preventative techniques, by killing unhealthy or mutant cancer cells. This new discovery could aid researchers to the development of new drugs to treat and prevent colon cancer. More research is needed to confirm SDs toxicity and to determine the best way to deliver SDs to patients, according to the researcher. However, she says the benefits could start now. “I would be comfortable recommending soy products as a change in diet that could protect against cancer", she added.

SOURCE: Ivanhoe Newswire, November 2009

Return to top

 
 
 Traffic, Dust Alert !

Traffic, Dust Linked To Asthma In Kids

Infants exposed to outdoor traffic pollution and indoor endotoxin are at increased risk for asthma, researchers say. Endotoxin -- a component of bacteria believed to trigger an immune response in humans -- is found in dust. University of Cincinnati College of Medicine researchers found persistent wheezing (an early warning sign of asthma and other lung conditions) in 36 percent of 3-year-olds who were exposed to high levels of traffic pollution and indoor endotoxin as infants. In comparison, wheezing was seen in 11 percent of children exposed to low levels of outdoor and indoor allergens as infants, and in 18 percent of children exposed to high levels of traffic pollution and low levels of indoor endotoxin. Endotoxin exposure alone appeared to have little effect on children, the study authors noted. "There is a clear synergistic effect from co-exposure to traffic-related particles and endotoxin above and beyond what you would see with a single exposure that can be connected to persistent wheezing by age 3," according to a research assistant professor of environmental health. "These two exposure sources -- when simultaneously present at high levels -- appear to work together to negatively impact the health of young children with developing lungs." "Traffic-related particles and endotoxin both seem to trigger an inflammatory response in the children monitored in this study. When put together, that effect is amplified to have a greater impact on the body's response," the scientist explained. "The earlier in life this type of exposure occurs, the more impact it may have long term. Lung development occurs in children up through age 18 or 20. Exposure earlier in life to both endotoxin and traffic will have a greater impact on developing lungs compared to adults whose lungs are already developed."

SOURCE: HealthDay News, November  2009

Return to top

 
 
 Higher Dose Better !

Heart Failure Drug May Help More In Higher Doses

For people with heart failure, high doses of the drug losartan, an angiotensin-receptor blocker (ARB), reduce the risk for hospital admission and death, a new study shows. Though ARBs are known to benefit people with heart failure, the study focused on whether dose level makes a difference. The study included 3,846 people in 30 countries who had heart failure, a left-ventricular ejection fraction of 40 percent or less and intolerance to angiotensin-converting-enzyme (ACE) inhibitors. The participants were randomly assigned to take 50 or 150 milligrams a day of losartan. After a median follow-up of 4.7 years, 43 percent of those in the high-dose group and 46 percent of those in the lower-dose group had died or were admitted to hospital for heart failure. Overall, the higher dose of losartan reduced the risk for death or admission for heart failure by 10 percent, according to the study. When looked at separately, the risk for death was 6 percent lower for the high-dose group, and the risk for hospital admission for heart failure was 13 percent lower. "These findings suggest that increased doses of an ARB are needed to achieve the maximum benefit for clinical outcomes and symptoms related to heart failure in this population," according to a cardiologist at Tufts Medical Center and Tufts University School of Medicine in Boston, and his fellow researchers.

SOURCE: HealthDay News, November  2009

Return to top

 
 
 Depression After Surgery !

Treating Depression After Surgery Speeds Recovery

A simple telephone intervention improved mood, physical functioning, and overall quality of life in patients who were depressed after heart bypass surgery, researchers reported in a late breaking clinical trial at the American Heart Association Scientific Sessions 2009. In the so-called Bypassing the Blues trial, 50 percent of patients who were depressed after having coronary artery bypass surgery saw improvements of at least 50 percent in their negative mood after participating in the intervention, compared with 29 percent of control patients who received usual care. Depressed men benefited most and were far less likely to be re-hospitalized for heart-related causes than men who got usual care, according to the researcher from the University of Pittsburgh, Pennsylvania. Depression after heart surgery "is often unrecognized," the scientist noted. When a patient still has symptoms, such as pain, the physician will order another stress test or other heart test "and they overlook the obvious sometimes. In the trial, researchers screened heart bypass patients for depression before they were discharged from the hospital. Screen-positive patients were contacted again two weeks later when they were at home to see if their depression was persisting. If so, they were randomly allocated to receive an 8-month course of telephone-delivered collaborative care or usual care.Patients in the collaborative care group received a workbook, mailed to them at home, which contained basic "talk therapy" approaches as well as recommendations for exercising, getting plenty of quality sleep, and staying connected socially. Antidepressants were provided if patients felt it necessary. Patients who were already taking antidepressants could have their dose changed or could switch to another medication, and suggestions were made for consults with local mental health specialists if patients were not improving, the researcher said. Trained nurse practitioners phoned the patients every other week at the start of the intervention and then once a month as the study progressed. This simple intervention proved effective in relieving depression after heart bypass surgery, the researcher reported. Patients should be screened for depression after heart bypass surgery, he said, because it occurs in roughly 25 percent of cases, and, as this study shows, treating depression speeds recovery..  

SOURCE: Reuters Health, November  2009

Return to top

 
 
 Optical Technology !

 New Polyp Detection Method Could Be Cost-Saver

Optical technology could help physicians detect small colorectal polyps during colonoscopies and save money, too, new research suggests. Colorectal cancer is the second-leading cause of death from cancer, outranked only by lung cancer. It will kill an estimated 49,920 people in the United States this year, according to the American Cancer Society. But early detection, which allows doctors to remove pre-cancerous polyps, can prevent deaths.  In the study, British researchers examined the records of the diagnosis of 363 small colorectal polyps that were found in 130 people. Their aim was to determine if optical diagnosis was accurate.  They found that optical technology allowed colonoscopists to accurately pinpoint up to 93 percent of small colorectal polyps. This is about the same level as histopathology. The researchers estimated that using optical diagnosis for the people in the study would have saved $22,000 in medical costs. By some estimates, use of optical technology instead of histopathology could save $95 million a year in the United States. "Optical diagnosis for small colonic polyps could become acceptable standard of care in routine non-academic clinical practice," the study authors concluded.

SOURCE: HealthDay News, November 2009.

Return to top

 
 

Products of SQUARE Pharmaceuticals Ltd.

  Product Cadnyl® 4 Tablet
  Generic Name

Perindopril Erbumine BP

  Strength

4 mg

  Dosage form Film Coated Tablet
  Therapeutic Category ACE inhibitor
  Product Flugal® 200 Capsule
Generic Name Fluconazole USP
Strength

200 mg

Dosage form Capsule
Therapeutic Category Systemic antifungal
  Product Virux® Suspension
  Generic Name Aciclovir
  Strength

200 mg/5 ml

  Dosage form Suspension
  Therapeutic Category Systemic Anti-virals (Excluding Anti-HIV)

Return to top

 

Copyright © 2009 SQUARE Pharmaceuticals Ltd. All rights reserved.